A-WIT Technologies Releases World's First Low Cost C Stamp(TM) Based Biotechnology Laboratory in a Box
New Biotechnology kits from A-WIT Technologies provide everything necessary to build a complete Biotechnology Laboratory, and support US and European power supplies.
Williamstown, NJ (PRWEB) June 11, 2009 -- A-WIT Technologies releases world's first low cost C Stamp&tra...
Statement From Michael Hansen, CEO of Elsevier's Health Sciences Division, Regarding Australia Based Sponsored Journal Practices Between 2000 and 2005
PHILADELPHIA, Pennysylvania, May 7 /PRNewswire-FirstCall/ -- Elsevier,
one of the world's leading publishers of scientific, technical, and medical
(STM) information products and services, announced today that Michael Hansen,
CEO of Elsevier's Health Sciences Division, issued the following stat...
AMG Launches EVOS fl, an 'Evolutionary' Fluorescence Microscope Based on Innovative EVOS Platform
New microscope streamlines workflow while providing the highest quality imaging.
Mill Creek, WA (PRWEB) April 27, 2009 -- Advanced Microscopy Group (a division of Westover Scientific, Inc.) announced today the launch of its newest microscope, the EVOS fl for fluores...
METTLER TOLEDO and AAPS: Utilization of Process Modeling and Advanced Process Control in QbD based Drug Development and Manufacturing
METTLER TOLEDO invites you to view our latest particle characterization technologies at the American Association of Pharmaceutical Scientists (AAPS) Workshop: Utilization of Process Modeling and Advanced Process Control in QbD based
Drug Development and Manufacturing.
Proximity Systems' LAN Based Electronic Lock Management System Offers Increased Security, Efficiency and Reporting Capability for Wall-Mounted WorkStations
HOUSTON, Feb. 16 /PRNewswire/ -- Proximity Systems will be announcing the availability of the LAN Based
Electronic Lock Management System for use in its retractable, wall-mounted WorkStations at the 2009 HIMSS Conference & Exhibition. The new patent-pending locking system simplifies and stream...
Novavax and Vivalis Sign a Research License Agreement to Use the EB66(R) Cell Line for the Production of Virus Like Particle Based Vaccines
ROCKVILLE, Md. and NANTES, France, Feb. 4 /PRNewswire-FirstCall/ -- NOVAVAX (Nasdaq: NVAX ) and Vivalis (NYSE Euronext: VLS) announced today the completion of a research license to use the Vivalis proprietary EB66(R) cell line, for the production of Novavax VLP based
vaccines. Through this colla...
GeneNews granted U.S. patent for Chagas disease based on Sentinel Principle(TM) platform
TORONTO, Jan. 13 /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced it has been granted U.S. Patent # 7,473,528 entitled "Method for the detection ...
Dry adhesive based on carbon nanotubes gets stronger, with directional gripping ability
The race for the best "gecko foot" dry adhesive got a new competitor this week with a stronger and more practical material reported in the journal Science by a team of researchers from four U.S. institutions.
Scientists have long been interested in the ability of gecko lizards to scurry up wall...
ThalesNano, Inc. Forms Collaborations with Leading US Universities based on the Award Winning H-Cube(R) and H-Cube Midi(TM)
Expanding chemistry and introducing continuous process chemistry to the next generation of chemists among the goals
BUDAPEST, Hungary, LONDON and PRINCETON, N.J., Oct. 6 /PRNewswire/ --
ThalesNano, Inc. today announced that it has signed agreements with a
number of academic organi...
New Opportunities in X-Ray Based Surgical Navigation With Ziehm NaviPort 3D
Ziehm Imaging and BrainLAB Improve Intra-Operative Imaging With Navigation for More Gentle, Less Invasive Surgery
NUREMBERG and MUNICH, Germany, October 6 /PRNewswire/ -- Ziehm Imaging
and BrainLAB have developed the Ziehm NaviPort 3D interface, representing
an important step fo...
Lixte Biotechnology Holdings Announces Filing of a New Patent Application for Cancer Therapy Based on Targeting a Biomarker by Novel Investigational Agents
EAST SETAUKET, N.Y., Aug. 19 /PRNewswire-FirstCall/ -- Lixte
Biotechnology Holdings, Inc. (OTC Bulletin Board: LIXT) announced today
that the National Institute of Neurological Disorders and Stroke (NINDS),
National Institutes of Health (NIH) and Lixte filed a joint patent
MS Drug Development Agreement Based on WEHI's Medicinal Chemistry
MELBOURNE, Australia, July 2 /PRNewswire/ -- Research conducted at The
Walter and Eliza Hall Institute (WEHI) has contributed significantly to a
major licensing agreement signed between Australian biotechnology company,
Bionomics, (ASX:BNO) and Germany-based pharmaceutical company, Merck
FDA Approves Quark IND for DGFi, an siRNA Therapeutic Based on Silence Therapeutics' Unique Proprietary Chemistry
Quark Pharmaceuticals to develop drug candidate for prevention and treatment of delayed graft function in kidney transplantation
LONDON, June 25 /PRNewswire/ -- Silence Therapeutics plc (London AIM:
SLN) today announces that the U.S. Food and Drug Administration (FDA) has
approved a Qua...
California's International Stem Cell Collaborations Must Be Based on Scientific Merit, Consumer Group Says
SANTA MONICA , Calif., June 18 /PRNewswire-USNewswire/ -- California's
plans to join in cooperative stem cell research efforts with Canada and the
Australian state of Victoria should be supported so long as they are based
on scientific merit, not merely the glamour and glitz of playing on the
Caliper Life Sciences Forms Alliance With Horizon Discovery to Provide Enhanced Solutions for Cancer Research Based on Isogenic Cell Lines
- CDAS Expands Offering to Include Screening for Targeted Cancer Drugs Using Genetically-Defined In-Vitro Human Disease Models -
HOPKINTON, Mass., April 9, 2008 /PRNewswire-FirstCall/ -- Caliper Life
Sciences, Inc. (Nasdaq: CALP ) today announced a partnership with Horizon
Mobidiag Releases First Microarray Based Rapid Test for Herpesvirus Identification
Prove-it Herpes Offers Considerable Cost Savings for Healthcare Industry by Identifying Eight Herpesviruses Simultaneously
HELSINKI, Finland, March 12 /PRNewswire/ -- The Finland-based
biotechnology company Mobidiag today announced the new Prove-it(TM) Herpes
test for the fast and re...
Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
EDMONTON, Dec. 17 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX
Venture Exchange: QPT) today announced that it has signed an agreement with
a multinational technology development company (the "Investor") to receive
$3,000,000 to develop oncology products based
on its SonoLight Technology...
Novo Nordisk Increased Operating Profit by 11% in the First Nine Months of 2007 Based on a 9% Sales Increase and an Improved Gross Margin
PRINCETON, N.J., Oct. 31 /PRNewswire-FirstCall/ -- Novo Nordisk (NYSE:
NVO), a global healthcare company, today released its financial statement
for the period January 1, 2007 to September 30, 2007. -- Novo Nordisk increased sales by 14% in local currencies and by 9% in Danish kroner due ...
NanoMaterials Technology to Conduct Process Development Feasibility Study with US Based Emerging Pharmaceutical Company
SINGAPORE, Oct. 25 /Xinhua-PRNewswire/ -- NanoMaterials Technology
("NMT") announced that it will conduct a feasibility study with a US based
emerging pharmaceutical company. As part of the feasibility agreement, NMT will apply its proprietary
technology, High Gravity Controlled Precipitation...
Panacea Pharmaceuticals Announces the Availability of BC Detect(SM), a Serum- Based Diagnostic Test for Breast Cancer
GAITHERSBURG, Md., Oct. 17 /PRNewswire/ -- Panacea Pharmaceuticals,
Inc. announced today that BC Detect(SM), the Company's serum-based breast
cancer diagnostic test, is now available from Panacea Laboratories. BC
Detect(SM) is a simple blood test that should facilitate the identification
Luminex Corporation Reaches Settlement With Rules Based Medicine, Inc.
AUSTIN, Texas, Oct. 15 /PRNewswire-FirstCall/ -- Luminex Corporation
(Nasdaq: LMNX ) today announced that it has settled the pending litigation
with Rules Based
Medicine, Inc ("RBM"). As part of the settlement, Luminex
received a cash payment of $12.5 million. The cash payment was made by RBM...
Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
VANCOUVER, Oct. 9 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,
Inc. (NASDAQ: ANPI , TSX: ANP), a global specialty pharmaceutical and
medical device company, today announced that it intends to file Premarket
Notification 510(k) documents with the U.S. Food and Drug Administration
GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
- Innovative approach to developing anti-infective medicines provides hope for combating problems of resistance -
PALO ALTO, Calif. and LONDON, Oct. 8 /PRNewswire/ -- Anacor
Pharmaceuticals and GlaxoSmithKline today announced that they have entered
into a worldwide strategic all...
Sigma-Aldrich and Ingenuity Systems Announce Partnership to Create E-Commerce Search Solution Based on Biological Knowledge
ST. LOUIS, Sept. 13 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq:
SIAL) and Ingenuity Systems today announced a partnership to develop a
revolutionary new search capability to enhance the Sigma-Aldrich Web-based
customer experience. Under the terms of the agreement, Sigma-Aldrich will
Berbees success is based on companys history and culture
MADISON, Wis. Berbee Information Networks Corp . President Paul Shain spoke on his companys history and culture March 31 as part of Accelerate Madisons monthly meeting. According to Shain, Berbees unique principles and culture allowed it to flourish during the aftermath of the dot-com era as ot...
Wisconsin based Graphics Distribution, Inc. purchased by Florida company
Glendale, Wis. Graphics Distribution, Inc. , a high-tech distribution and product support services company, will become a wholly owned subsidiary of Video Without Boundaries, Inc.
VWB, a Florida-based provider of interactive, media-convergent home entertainment devices, announced Monday it s...
The measurement of DNA condensation and mitochondrial changes during apoptosis and necrosis in cell based assays
Key words: In Cell Analyzer • apoptosis • multiplexing • cell based
Apoptosis represents a gene-directed, morphologically and biochemically distinct form of programmed cell death. Inappropriate control of apoptosis is associated...
Cloning Based on Efficient Three-Fragment Assembly
The efficiency of the Rapid DNA Ligation Kit from
Roche Molecular Biochemicals was compared with
standard and optimized conventional ligation procedures.
The reactions gener...
DOE awards $377 million in funding for 46 energy frontier research centers
...ponse to a solicitation issued by the U.S. Department of Energy Office of Science in 2008 and announced on April 27, 2009. Selection of the EFRCs was based
on a rigorous merit review process utilizing outside panels composed of scientific experts. In total, the EFRC initiative represents a planned DOE co...
KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid
...Private Securities Litigation Reform Act of 1995 ("PSLRA") and which may be based
on or include assumptions concerning the operations, future results and pro..., are forward-looking statements.
All forward-looking statements are based
on current expectations and are subject to risk and uncertainties. In conne...
Schering-Plough Shareholders Approve Merger With Merck
...ng statements do not relate strictly to historical or current facts and are based
on current expectations or forecasts of future events. You can identify th...her stakeholders served by its colleagues around the world. The company is based
in Kenilworth, N.J., and its Web site is www.schering-p l ough.com .
REPEL-CV(TM) Adhesion Barrier Receives Endorsement of Kids With Heart
...rily focused on the commercialization of REPEL-CV(TM) Bioresorbable Adhesion Barrier and the advancement and expansion of product development programs based
on its proprietary bioresorbable polymer technologies.
Statements in this press release that are not statements of historical fact, constitute...
SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results
...ritional products by Perrigo. Royalty payments are based
on Perrigo's net profits from the sale of CDT-base...d $473,711 in restricted cash as of June 30, 2009. based
on our current operating plan, we anticipate that ...ockholders.
About SCOLR Pharma:
in Bothell, Washington, SCOLR Pharma, Inc. is a sp...
Novavax Reports Second Quarter 2009 Financial Results
...the sale of common stock to Cadila of $10.7 million and proceeds from the sale of stock under the ATM program of $14.0 million. Novavax believes that based
on the balance of cash and short-term investments at June 30, 2009, along with the proceeds from its transaction with ROVI of $3.0 million and the pro...
Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product
...y provides an extensive range of products into multiple medical markets, including sports medicine, spine, and endovascular. Many of the products are based
on the Company's significant expertise in the design, development, manufacturing and processing of absorbable biomaterials, which has led to partnersh...
Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results
...amphetamine proof-of-concept study by the end of the third quarter of 2009. based
on the results of this analysis, we will evaluate what measures, if any, co... pending in more than 30 countries. The Company's initial product candidate based
on vigabatrin is CPP-109. CPP-109 has been granted "Fast Track" status by t...
NeurogesX Reports Second Quarter 2009 Results
... per share for the three months ended June 30, 2009 and 2008, respectively, based
on weighted average shares outstanding of 17.6 million and 17.5 million, re...e Company's operations for at least the next 12 months. Such statements are based
on management's current expectations, but actual results may differ materia...
Viral Genetics Creates Subsidiary to Develop Cancer Therapy
.... D., that appears to explain TNP and provide a means to optimize therapies based
on TNP for future clinical trials. Viral Genetics believes that its investigational HIV/AIDS drug based
on TNP, called VGV-1, represents a unique approach to treating HIV due to t...
ThermoGenesis Announces Expanded Collaboration With Celling Technologies
...any's bone marrow products, MXP(TM) MarrowXpress(TM) ("MXP") and Res-Q(TM) 60 BMC ("Res-Q"). Celling is a leading distributor of orthopedic products, based
As part of this expanded collaboration, ThermoGenesis and Celling will share in the funding for clinical studies to demonstrate the...
Synthetech Reports First Quarter Fiscal 2010 Results
...ll performance for the balance of fiscal year 2010 based
on a reasonable $4.6 million order backlog, a robu.... Variability in Synthetech's level of revenue is based
primarily on its participation in large-scale cust...s.
Synthetech, Inc., based
in Albany, Oregon, is a fine chemicals company spe...